{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T17:48:57Z","timestamp":1787161737299,"version":"build-2736575974"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Egypt Natl Canc Inst"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s43046-019-0011-2","type":"journal-article","created":{"date-parts":[[2019,12,30]],"date-time":"2019-12-30T14:02:37Z","timestamp":1577714557000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Signification of forkhead box A1 (FOXA1) expression in thyroid cancers"],"prefix":"10.1186","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6964-075X","authenticated-orcid":false,"given":"Nabiha","family":"Missaoui","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sameh","family":"Chouaibi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarra","family":"Limam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nozha","family":"Mhamdi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thouraya","family":"Zahmoul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hajer","family":"Hamchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moncef","family":"Mokni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sihem","family":"Hmissa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,12,30]]},"reference":[{"key":"11_CR1","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394\u2013424.","journal-title":"CA Cancer J Clin"},{"key":"11_CR2","doi-asserted-by":"publisher","first-page":"2669","DOI":"10.1002\/ijc.25490","volume":"127","author":"N Missaoui","year":"2010","unstructured":"Missaoui N, Trabelsi A, Parkin DM, Jaidene L, Chatti D, Mokni M, et al. Trends in the incidence of cancer in the Sousse region, Tunisia, 1993-2006. Int J Cancer. 2010;127:2669\u201377.","journal-title":"Int J Cancer"},{"key":"11_CR3","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1507\/endocrj.EJ17-0026","volume":"64","author":"T Takano","year":"2017","unstructured":"Takano T. Natural history of thyroid cancer [review]. Endocr J. 2017;64:237\u201344.","journal-title":"Endocr J"},{"key":"11_CR4","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1038\/nrendo.2017.76","volume":"13","author":"E Molinaro","year":"2017","unstructured":"Molinaro E, Romei C, Biagini A, Sabini E, Agate L, Mazzeo S, et al. Anaplastic thyroid carcinoma: from clinicopathology to genetics and advanced therapies. Nat Rev Endocrinol. 2017;13:644\u201360.","journal-title":"Nat Rev Endocrinol"},{"key":"11_CR5","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1097\/CCO.0000000000000340","volume":"29","author":"AL Maia","year":"2017","unstructured":"Maia AL, Wajner SM, Vargas CV. Advances and controversies in the management of medullary thyroid carcinoma. Curr Opin Oncol. 2017;29:25\u201332.","journal-title":"Curr Opin Oncol"},{"key":"11_CR6","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.mrrev.2012.09.002","volume":"752","author":"G Figlioli","year":"2013","unstructured":"Figlioli G, Landi S, Romei C, Elisei R, Gemignani F. Medullary thyroid carcinoma (MTC) and RET proto-oncogene: mutation spectrum in the familial cases and a meta-analysis of studies on the sporadic form. Mutat Res. 2013;752:36\u201344.","journal-title":"Mutat Res"},{"key":"11_CR7","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1002\/hed.25463","volume":"41","author":"K Saltiki","year":"2019","unstructured":"Saltiki K, Simeakis G, Anagnostou E, Zapanti E, Anastasiou E, Alevizaki M. Different outcomes in sporadic versus familial medullary thyroid cancer. Head Neck. 2019;41:154\u201361.","journal-title":"Head Neck"},{"key":"11_CR8","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1111\/his.13348","volume":"72","author":"ZW Baloch","year":"2018","unstructured":"Baloch ZW, LiVolsi VA. Special types of thyroid carcinoma. Histopathology. 2018;72:40\u201352.","journal-title":"Histopathology"},{"key":"11_CR9","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.humpath.2017.05.007","volume":"65","author":"D Nonaka","year":"2017","unstructured":"Nonaka D. A study of FoxA1 expression in thyroid tumors. Hum Pathol. 2017;65:217\u201324.","journal-title":"Hum Pathol"},{"key":"11_CR10","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1111\/j.1365-2265.2009.03666.x","volume":"72","author":"JAA Meijer","year":"2010","unstructured":"Meijer JAA, Le Cessie S, Van Den Hout WB, Kievit J, Schoones JW, Romijn JA, et al. Calcitonin and carcinoembryonic antigen doubling times as prognostic factors in medullary thyroid carcinoma: a structured meta-analysis. Clin Endocrinol. 2010;72:534\u201342.","journal-title":"Clin Endocrinol"},{"key":"11_CR11","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.ydbio.2017.09.002","volume":"433","author":"Q Lan","year":"2018","unstructured":"Lan Q, Cao M, Kollipara RK, Rosa JB, Kittler R, Jiang H. FoxA transcription factor Fork head maintains the intestinal stem\/progenitor cell identities in Drosophila. Dev Biol. 2018;433:324\u201343.","journal-title":"Dev Biol"},{"key":"11_CR12","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1042\/BSR20110046","volume":"32","author":"GM Bernardo","year":"2012","unstructured":"Bernardo GM, Keri RA. FOXA1: a transcription factor with parallel functions in development and cancer. Biosci Rep. 2012;32:113\u201330.","journal-title":"Biosci Rep"},{"key":"11_CR13","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/j.gde.2010.06.005","volume":"20","author":"KH Kaestner","year":"2010","unstructured":"Kaestner KH. The FoxA factors in organogenesis and differentiation. Curr Opin Genet Dev. 2010;20:527\u201332.","journal-title":"Curr Opin Genet Dev"},{"key":"11_CR14","first-page":"397","volume":"22","author":"HY Gan","year":"2018","unstructured":"Gan HY, Li N, Zhang Q, Feng ZZ. Silencing FOXA1 gene regulates liver cancer cell apoptosis and cell proliferation. Eur Rev Med Pharmacol Sci. 2018;22:397\u2013404.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"11_CR15","doi-asserted-by":"publisher","first-page":"34962","DOI":"10.1038\/srep34962","volume":"6","author":"M Fournier","year":"2016","unstructured":"Fournier M, Bourriquen G, Lamaze FC, Cote MC, Fournier E, Joly-Beauparlant C, et al. FOXA and master transcription factors recruit mediator and cohesin to the core transcriptional regulatory circuitry of cancer cells. Sci Rep. 2016;6:34962.","journal-title":"Sci Rep"},{"key":"11_CR16","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.molcel.2016.03.001","volume":"62","author":"M Iwafuchi-Doi","year":"2016","unstructured":"Iwafuchi-Doi M, Donahue G, Kakumanu A, Watts JA, Mahony S, Pugh BF, et al. The pioneer transcription factor FoxA maintains an accessible nucleosome configuration at enhancers for tissue-specific gene activation. Mol Cell. 2016;62:79\u201391.","journal-title":"Mol Cell"},{"key":"11_CR17","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/nrc3263","volume":"12","author":"KM Jozwik","year":"2012","unstructured":"Jozwik KM, Carroll JS. Pioneer factors in hormone-dependent cancers. Nat Rev Cancer. 2012;12:381\u20135.","journal-title":"Nat Rev Cancer"},{"key":"11_CR18","doi-asserted-by":"publisher","first-page":"3885","DOI":"10.1038\/emboj.2011.340","volume":"30","author":"MA Augello","year":"2011","unstructured":"Augello MA, Hickey TE, Knudsen KE. FOXA1: master of steroid receptor function in cancer. EMBO J. 2011;30:3885\u201394.","journal-title":"EMBO J"},{"key":"11_CR19","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.gene.2018.11.022","volume":"685","author":"C Huang","year":"2019","unstructured":"Huang C, Liu J, Xiong B, Yonemura Y, Yang X. Expression and prognosis analyses of forkhead box A (FOXA) family in human lung cancer. Gene. 2019;685:202\u201310.","journal-title":"Gene"},{"key":"11_CR20","doi-asserted-by":"crossref","first-page":"101042831770621","DOI":"10.1177\/1010428317706210","volume":"39","author":"LL Wang","year":"2017","unstructured":"Wang LL, Xiu YL, Chen X, Sun KX, Chen S, Wu DD, et al. The transcription factor FOXA1 induces epithelial ovarian cancer tumorigenesis and progression. Tumour Biol. 2017;39:1010428317706210.","journal-title":"Tumour Biol"},{"key":"11_CR21","doi-asserted-by":"publisher","first-page":"3680","DOI":"10.1158\/1078-0432.CCR-08-3155","volume":"15","author":"C Nucera","year":"2009","unstructured":"Nucera C, Eeckhoute J, Finn S, Carroll JS, Ligon AH, Priolo C, et al. FOXA1 is a potential oncogene in anaplastic thyroid carcinoma. Clin Cancer Res. 2009;15:3680\u20139.","journal-title":"Clin Cancer Res"},{"key":"11_CR22","volume-title":"WHO classification of tumours of endocrine organs","author":"RV Lloyd","year":"2017","unstructured":"Lloyd RV, Osamura RY, Kloppel G, Rosai J. WHO classification of tumours of endocrine organs. Lyon: IARC Press; 2017."},{"key":"11_CR23","doi-asserted-by":"publisher","first-page":"431","DOI":"10.3727\/096504018X15201058168730","volume":"27","author":"X Chen","year":"2019","unstructured":"Chen X, Li M, Zhou H, Zhang L. miR-132 targets FOXA1 and exerts tumor-suppressing functions in thyroid cancer. Oncol Res. 2019;27:431\u20137.","journal-title":"Oncol Res"},{"key":"11_CR24","doi-asserted-by":"publisher","first-page":"5018","DOI":"10.3892\/ol.2017.6745","volume":"14","author":"S Zhang","year":"2017","unstructured":"Zhang S, Liu Q, Zhang Q, Liu L. MicroRNA-30a-5p suppresses proliferation, invasion and tumor growth of hepatocellular cancer cells via targeting FOXA1. Oncol Lett. 2017;14:5018\u201326.","journal-title":"Oncol Lett"},{"key":"11_CR25","doi-asserted-by":"publisher","first-page":"13216","DOI":"10.18632\/oncotarget.3916","volume":"6","author":"C Dou","year":"2015","unstructured":"Dou C, Wang Y, Li C, Liu Z, Jia Y, Li Q, et al. MicroRNA-212 suppresses tumor growth of human hepatocellular carcinoma by targeting FOXA1. Oncotarget. 2015;6:13216\u201328.","journal-title":"Oncotarget"},{"key":"11_CR26","doi-asserted-by":"publisher","first-page":"4135","DOI":"10.3892\/etm.2016.3880","volume":"12","author":"J Liu","year":"2016","unstructured":"Liu J, Chen B, Yue B, Yang J. MicroRNA-212 suppresses the proliferation and migration of osteosarcoma cells by targeting forkhead box protein A1. Exp Ther Med. 2016;12:4135\u201341.","journal-title":"Exp Ther Med"},{"key":"11_CR27","doi-asserted-by":"crossref","first-page":"13139","DOI":"10.18632\/oncotarget.7545","volume":"7","author":"X Zhu","year":"2016","unstructured":"Zhu X, Li D, Yu F, Jia C, Xie J, Ma Y, et al. miR-194 inhibits the proliferation, invasion, migration, and enhances the chemosensitivity of non-small cell lung cancer cells by targeting forkhead box A1 protein. Oncotarget. 2016;7:13139\u201352.","journal-title":"Oncotarget"},{"key":"11_CR28","doi-asserted-by":"publisher","first-page":"5143","DOI":"10.1096\/fj.201801470R","volume":"33","author":"YZ Wu","year":"2019","unstructured":"Wu YZ, Chan KYY, Leung KT, Lam HS, Tam YH, Lee KH, et al. Dysregulation of miR-431 and target gene FOXA1 in intestinal tissues of infants with necrotizing enterocolitis. FASEB J. 2019;33:5143\u201352.","journal-title":"FASEB J"},{"key":"11_CR29","doi-asserted-by":"publisher","first-page":"3519","DOI":"10.1242\/dev.126581","volume":"142","author":"E Johansson","year":"2015","unstructured":"Johansson E, Andersson L, \u00d6rnros J, Carlsson T, Ingeson-Carlsson C, Liang S, et al. Revising the embryonic origin of thyroid C cells in mice and humans. Development. 2015;142:3519\u201328.","journal-title":"Development"}],"container-title":["Journal of the Egyptian National Cancer Institute"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s43046-019-0011-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s43046-019-0011-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s43046-019-0011-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,24]],"date-time":"2023-09-24T09:48:42Z","timestamp":1695548922000},"score":1,"resource":{"primary":{"URL":"https:\/\/jenci.springeropen.com\/articles\/10.1186\/s43046-019-0011-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["11"],"URL":"https:\/\/doi.org\/10.1186\/s43046-019-0011-2","relation":{},"ISSN":["2589-0409"],"issn-type":[{"value":"2589-0409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"9 July 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 December 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have received a written informed consent from patients to participate in the study.This study was approved by the local Human Ethics Committee at the Farhat Hached University Hospital of Sousse (Tunisia), and it conformed to the provisions of the Declaration of Helsinki.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare that they have received a written informed consent from patients to publish their data.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"11"}}